跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,526 条关于
“MPS Society”
全部
7,526
临床试验
3,161
药物
338
机构
151
资讯
3,876
11年前
NICE Provisionally Approves BioMarin's Vimizim for Ultra-Rare Morquio Disease with Real-World Data Requirements
前天
FDA Approves Fayuvi, First-Ever Gene Therapy for Sanfilippo Syndrome Type A
2年前
Denali Therapeutics Plans Accelerated Approval Filing for Tividenofusp Alfa in MPS II
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
去年
Four Promising Gene and Cell Therapies Challenge Aldurazyme's Dominance in MPS I Treatment
去年
REGENXBIO and Nippon Shinyaku Partner to Advance Gene Therapies for MPS I and MPS II
去年
Regenxbio Expands MPS I Gene Therapy Trial After Initial Data Review
去年
Immusoft Reports Breakthrough Results from First-Ever Engineered B Cell Therapy in MPS I Clinical Trial
去年
Biosimilar Laronidase Shows Comparable Efficacy to Reference Drug in MPS I Patients
去年
Immusoft's Engineered B-Cell Therapy Shows Promise in MPS I Trial
第 1 页,共 388 页
上一页
下一页